Premium
Meta‐analysis: Dose of ketamine reduces symptoms of suicidal ideation rapidly
Publication year - 2018
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30285
Subject(s) - ketamine , suicidal ideation , medicine , ideation , psychiatry , meta analysis , anesthesia , psychology , poison control , emergency medicine , suicide prevention , cognitive science
A systematic review of 10 studies has found that a single intravenous dose of ketamine reduced suicidal thoughts within a day in patients with a psychiatric disorder, with the effects of the dose lasting up to one week. The researchers stated that although these results should be considered preliminary, they suggest that ketamine appears promising as a rapid‐acting treatment for patients at acute risk of suicide. Results were published online Oct. 3 in the American Journal of Psychiatry .